Does TIRZEPATIDE Cause Injection site erythema? 3,844 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,844 reports of Injection site erythema have been filed in association with TIRZEPATIDE (Zepbound). This represents 3.9% of all adverse event reports for TIRZEPATIDE.
3,844
Reports of Injection site erythema with TIRZEPATIDE
3.9%
of all TIRZEPATIDE reports
0
Deaths
14
Hospitalizations
How Dangerous Is Injection site erythema From TIRZEPATIDE?
Of the 3,844 reports, 14 (0.4%) required hospitalization, and 1 (0.0%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIRZEPATIDE. However, 3,844 reports have been filed with the FAERS database.
What Other Side Effects Does TIRZEPATIDE Cause?
Incorrect dose administered (23,301)
Injection site pain (10,989)
Nausea (10,018)
Off label use (7,007)
Extra dose administered (6,774)
Diarrhoea (5,463)
Vomiting (4,635)
Injection site haemorrhage (4,389)
Accidental underdose (3,897)
Constipation (3,417)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
DULAGLUTIDE (1,538)
Which TIRZEPATIDE Alternatives Have Lower Injection site erythema Risk?
TIRZEPATIDE vs TISAGENLECLEUCEL
TIRZEPATIDE vs TISLELIZUMAB
TIRZEPATIDE vs TISOTUMAB VEDOTIN
TIRZEPATIDE vs TISOTUMAB VEDOTIN-TFTV
TIRZEPATIDE vs TITANIUM DIOXIDE\ZINC